<DOC>
	<DOCNO>NCT01831141</DOCNO>
	<brief_summary>Congenital solitary kidney ( CSK ) disorder cause abnormal development one two kidney . The reported incidence range 1:450-3200 . It debate whether CSK benign condition . A variable risk develop proteinuria ( 11-27 % ) , hypertension ( 0-60 % ) chronic kidney damage ( 3.5-30 % ) described . This knowledge derive mainly retrospective study perform tertiary medical center difficult compare follow reason : number individual evaluate , length follow-up outcome study . The aim longitudinal study ass , cohort child congenital solitary kidney , 10 year follow-up period : 1 ) rate develop proteinuria , hypertension chronic kidney disease correspond potential prognostic factor . 2 ) role new biomarkers glomerular ( Cystatin C ) tubular damage ( NGAL , NAG , B2-microglobulin ) predict appearance chronic kidney damage .</brief_summary>
	<brief_title>Long Term Outcome Congenital Solitary Kidney</brief_title>
	<detailed_description>Congenital Solitary kidney ( CSK ) disorder cause abnormal development one two kidney . This abnormality either anatomical , caused unilateral renal agenesis ( RAG ) , functional , cause extreme form dysplasia ( renal aplasia-RAP multicystic dysplastic kidney disease-MCKD ) . The reported incidence 1:450-3200 difference two sex . CSK subgroup large family Congenital Anomalies Kidney Urinary Tract ( CAKUT ) , cause abnormal embryologic development . Physiologically , development kidney begin 3rd week gestation proceeds series phase : pronephros , mesonephros , metanephros . While abnormality early pronephros-mesonephros phase lead renal agenesis , aberrant metanephros phase cause wide spectrum CAKUT . CAKUT lead cause chronic ( 50 % ) end stage ( 40 % ) kidney disease child . While risk well know phenotype ( e.g . bilateral renal hypodysplasia posterior urethral valve ) , whether CSK benign condition , subject recent debate . The knowledge natural history CSK originate mainly retrospective study often perform tertiary medical center difficult compare several reason : number individual study vary considerably underlie CSK disorder ( RAG , MCKD RAP ) , length follow-up type outcome consider . These study show extremely variable risk develop proteinuria ( 11-27 % ) , hypertension ( 0-60 % ) , chronic kidney disease ( 3.5-30 % ) . So many difficulty prevent u understanding : ) phenotype ( RAG , MCKD RAP ) risk factor could influence progression adverse outcome ; b ) whether compensatory hypertrophy result hyperfiltration act protective mechanism . Recently , Sanna-Cherchi et al . retrospectively analyzed long-term renal outcome 300 child CAKUTs . With simple selection criterion , dialysis-free survival birth model account concomitant vesicoureteral reflux , age diagnosis , hypertension , proteinuria , serum creatinine concentration . Surprisingly analysis reveal patient solitary kidney probability nearly 50 % require dialysis 30 year age . This clinical outcome raise possibility subclinical defect could present congenital solitary kidney may account poor prognosis . This hypothesis also support fact long-term prognosis individual acquire single kidney ( e.g . transplant donor subject nephrectomized Wilm 's tumor ) appear excellent . This report high risk poor outcome CSK patient highlight need understanding : 1 ) rate factor determine progression end-stage renal disease ; 2 ) development biomarkers improve early detection . Usually , child CSK always subject long term follow-up , monitor involves plasma creatinine concentration , proteinuria ultrasonography . Because case endstage renal disease child result tubulointerstitial rather glomerular disorder , serum creatinine urine protein determination relatively insensitive . New biomarkers available facilitate early identification change renal function become irreversible . These biomarkers glomerular ( serum Cystatin C ) tubular damage ( urine alfa-1 beta-2 microglobulin , urine lysozyme , serum urine neutrophil gelatinase associate lipocalin ( NGAL ) , urine Na+/H+ exchanger ( NHE3 ) , urine Kidney injury molecule 1 ( KIM1 ) , urine N-acetyl-beta-D-glucosaminidase ( NAG ) , already validate various kidney disease ( acute renal failure , nephrotic syndrome , etc ) , could useful early identification damage CSK patient . The aim longitudinal study ass , cohort child CSK , 10-year follow-up period : 1. rate develop proteinuria , hypertension chronic kidney disease potential prognostic factor . 2. role new biomarkers glomerular tubular damage predict appearance chronic kidney damage . Study population : Study group : male female child , age 0-18 year , diagnose CSK , document renal ultrasonography confirm dimercaptosuccinic acid ( DMSA ) Scan . Written inform consent obtain . Children chronic renal failure , posterior urethral valve , diabetes , heart and/or vascular disease autoimmune disease exclude . Subjects enrol Paediatric Nephrology Department Sant'Orsola Malpighi Hospital , Bologna , and/or outpatient 1st April 2010 30th April 2013 ; follow-up subject continue 10 year . At baseline child ass : 1 . Medical history ; 2 . Physical examination ( anthropometric blood pressure measurement ) ; 3 . Kidney urinary tract ultrasonography ( US ) ; 4 . Voiding cystourethrography ( VCUG ) ; 5 . Clinical laboratory assessment : complete blood count , serum electrolyte , serum creatinine , serum urea , serum cystatin C , urine analysis , urine creatinine , microalbuminuria , urine electrolyte , urine α1-microglobulin , urine β2-microglobulin , urine lysozyme , serum urine NGAL , urine NHE3 , urine KIM1 , urine NAG ; 6 . 99-technetium diethylene triamine pentaacetic acid scintigraphy ( DTPA ) ( DTPA scan ) child age 2 year . Patient follow-up monitoring : 1 . Clinical examination height , weight , BMI , blood pressure every six month child 2 year every year child age 3 year ; 2 . Biochemistry ( every six month child 2 year every year child age 3 year ) : complete blood count , serum electrolyte , serum creatinine , serum urea , serum cystatin C , urine analysis , urine creatinine , microalbuminuria , urine electrolyte , urine α1-microglobulin , urine β2-microglobulin , urine lysozyme , serum urine NGAL , urine NHE3 , urine KIM1 , urine NAG ; 3 . Kidney urinary tract US evaluation renal length ( every six month child 2 year every year child age 3 year ) ; 4 . DTPA scan : If age ≤ 2 year : 2 , 5 10 ten year ; If age &gt; 2 year : entry every five year ; 5 . Ambulatory blood pressure measurement : If age ≤ 7 year : 7 year , 10 year end follow-up ; If age &gt; 7 year entry every five year . The following epidemiological , clinical laboratory data collect : Epidemiological data : - Sex ; - Age diagnosis ; - Ethnicity ; - History . Clinical data : - Height , weight BMI visit , - Blood pressure measurement visit . Laboratory data : • Complete blood count , serum electrolyte , serum creatinine , serum urea , serum cystatin C , urine analysis , urine creatinine , microalbuminuria , urine electrolyte , urine α1-microglobulin , urine β2-microglobulin , urine lysozyme , serum urine NGAL , urine NHE3 , urine KIM1 , urine NAG visit . Instrumental data : - US renal length visit ; - Glomerular filtration rate evaluate DTPA scan ; - Ambulatory blood pressure meas</detailed_description>
	<mesh_term>Urogenital Abnormalities</mesh_term>
	<criteria>1 . Age 0 18 year 2 . Congenital Solitary Kidney 3 . Male female sex 4 . Written Informed consent obtain Children chronic renal failure , posterior urethral valve , diabetes , heart and/or vascular disease autoimmune disease exclude . Subjects enrol 1 . Age &gt; 18 year 2 . Chronic renal failure 3 . Posterior urethral valve 4 . Diabetes 5 . Heart and/or vascular disease 6 . Autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Congenital Solitary Kidney</keyword>
	<keyword>Glomerular filtration rate</keyword>
	<keyword>Chronic kidney damage</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Proteinuria</keyword>
</DOC>